Process and apparatus for fragmenting biomaterials

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4352831, 4352851, 422 99, 422243, 935 19, 239338, C12Q 168, C12M 100, C12N 1510

Patent

active

055061001

ABSTRACT:
Described is an improved process for fragmenting a biomaterial and isolating and recovering a component thereof. The preferred improved process includes the step of performing the fragmentation by nebulizing a liquid medium containing the biomaterial. A preferred process for fragmenting isolated DNA includes the step of nebulizing a fluid containing the DNA. This preferred process provides randomness superior to prior known DNA fragmentation methods, as well as other important advantages. Improved nebulization devices are also described.

REFERENCES:
patent: Re33642 (1991-07-01), Lester
patent: 4161282 (1979-07-01), Erb
patent: 4560519 (1985-12-01), Cerny
patent: 4612926 (1986-09-01), Boiarski
patent: 4805609 (1989-02-01), Robeas et al.
Young, et al. "Continuous Aerosol Therapy System Using A Modified Collision Nebulizer" J. Clin. Microbiol. 5(2) 131-136 1977.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process and apparatus for fragmenting biomaterials does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process and apparatus for fragmenting biomaterials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process and apparatus for fragmenting biomaterials will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-138059

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.